Cardinal Health, Inc. $CAH Stock: Knights of Columbus Asset Advisors LLC Lowers Stake

Knights of Columbus Asset Advisors LLC cut its holdings in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 19.7% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 47,414 shares of the company’s stock after selling 11,661 shares during the quarter. Knights of Columbus Asset Advisors LLC’s holdings in Cardinal Health were worth $10,550,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of CAH. BlackRock Inc. bought a new position in Cardinal Health during the second quarter worth $6,293,115,000. Wellington Management Group LLP grew its holdings in Cardinal Health by 247.5% in the second quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company’s stock worth $3,530,206,000 after purchasing an additional 10,584,119 shares during the period. Bank of America Corp DE bought a new stake in Cardinal Health in the second quarter valued at $689,066,000. Legal & General Group Plc bought a new stake in Cardinal Health in the second quarter valued at $438,870,000. Finally, Bank of New York Mellon Corp bought a new stake in Cardinal Health in the second quarter valued at $308,640,000. 87.17% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on CAH. UBS Group increased their price objective on shares of Cardinal Health from $280.00 to $295.00 and gave the stock a “buy” rating in a research report on Friday, October 16th. Weiss Ratings upgraded Cardinal Health from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Monday. Evercore reaffirmed an “outperform” rating and issued a $270.00 target price on shares of Cardinal Health in a research report on Wednesday, August 12th. Leerink Partners set a $292.00 price target on Cardinal Health in a research note on Tuesday, August 11th. Finally, Robert W. Baird increased their price target on Cardinal Health from $251.00 to $274.00 and gave the stock an “outperform” rating in a report on Wednesday, August 12th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $275.62.

Read Our Latest Stock Analysis on Cardinal Health

Cardinal Health Trading Up 1.0%

NYSE CAH opened at $276.96 on Wednesday. The company has a market cap of $64.02 billion, a P/E ratio of 35.83, a PEG ratio of 1.60 and a beta of 0.53. The company has a fifty day simple moving average of $242.08 and a 200 day simple moving average of $224.22. Cardinal Health, Inc. has a 12-month low of $180.45 and a 12-month high of $286.29.

Cardinal Health (NYSE:CAH – Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The company reported $3.26 earnings per share for the quarter, topping the consensus estimate of $2.94 by $0.32. Cardinal Health had a net margin of 0.71% and a negative return on equity of 102.72%. The firm had revenue of $67.51 billion for the quarter, compared to the consensus estimate of $66.67 billion. During the same quarter in the prior year, the company posted $2.55 earnings per share. The business’s revenue was up 5.5% on a year-over-year basis. Sell-side analysts predict that Cardinal Health, Inc. will post 12.96 EPS for the current year.

Insider Activity at Cardinal Health

In related news, CEO Jason M. Hollar sold 44,529 shares of the firm’s stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $236.18, for a total value of $10,516,859.22. Following the transaction, the chief executive officer owned 190,603 shares of the company’s stock, valued at approximately $45,016,616.54. This trade represents a 18.94% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Deborah Weitzman sold 7,354 shares of Cardinal Health stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $235.45, for a total value of $1,731,499.30. Following the transaction, the chief executive officer owned 77,901 shares of the company’s stock, valued at $18,341,790.45. This trade represents a 8.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 210,271 shares of company stock valued at $49,626,657 over the last quarter. 0.12% of the stock is currently owned by company insiders.

Cardinal Health Company Profile

(Free Report)

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.

Featured Stories

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.